Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hidden genetic disorder found in chronic pain patients?

NCT ID NCT02450604

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested 776 people with chronic pain of unknown cause to see if they had Fabry disease, a rare inherited disorder that can cause pain, kidney, heart, and nerve problems. Researchers used enzyme tests in men and genetic tests in women to find cases. The goal was to see how common Fabry disease is in this group and help diagnose it earlier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify Fabry disease earlier in people with unexplained chronic pain, leading to better management.
What could go wrong
This is an observational study, not a treatment trial. It only looks for the disease and does not test any therapy, so it cannot directly improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

776 people

The number who actually took part.

Started

Mar 2015

Finished

Dec 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients of both sex, * aged from 6 to 80, * with chronic pains of unknown aetiology including: acroparesthesias, and/or pain crises evolving more than 3 months, continued neuropathic evolving more than 3 months, and/or multiple pains evolving more than 3 months and/or recurrent abdominal crises of pain who come for a clinical visit in the pain Centres of France. Exclusion Criteria: * chronic pain of known cause

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Anesthésie, Hôpital Raymond Poincaré

    Garches, 92380, France

  • CETD La Timone, AP-HM

    Marseille, 13385, France

  • CeRCa, Unité de Neuromyologie, CHU de Fort de France

    FORT de France, Martinique, 97261, France

  • Centre Antidouleurs, CHU de Reims

    Reims, 51092, France

  • Centre Douleurs Chroniques, CH de la Côte Basque

    Bayonne, 64109, France

  • Centre Douleurs Chroniques, CHU de Bordeaux

    Bordeaux, 33076, France

  • Centre d'Analgésie Pédiatrique, Equipe Régionale Ressource en Soins Palliatifs-Equipe " Enfant-Do ", CHU de Toulouse

    Toulouse, 31059, France

  • Centre d'Analgésie, CHRU Lapeyronie

    Montpellier, 34295, France

  • Centre d'Evaluation et de Traitement de la Douleur, CHU de Nîmes

    Nîmes, 30029, France

  • Centre d'évaluation et de traitement de la Douleur, Hôpital Pierre-Paul Ricquet

    Toulouse, 31059, France

  • Centre de la Douleur, CHRU de Strasbourg

    Strasbourg, 67091, France

  • Centre de la douleur de l'Adulte et de l'Enfant, CHU de Grenoble

    Grenoble, 38043, France

  • Cs douleur chronique GHSR, CHU Sud Réunion

    Saint-Pierre, La Réunion, 97448, France

  • Médecine - Consultations Douleur, CH de La Réole

    La Réole, 33192, France

  • Pole enfant - CETD Salengro, CHRU de Lille

    Lille, 59037, France

  • Pôle Anesthésie Consultation douleur, CHRU de Lille

    Lille, 59037, France

  • Service d'Explorations Fonctionnelles et Consultations Neurologiques, CH Lyon-Sud

    Pierre-Bénite, 69495, France

  • Service de Médecine de la Douleur et de Médecine Palliative, Hôpital Lariboisière-APHP

    Paris, 75475, France

  • Service de lutte contre la douleur et d'Anesthésie, CH Périgueux

    Périgueux, 24 019, France

  • Service de médecine Polyvalent, CH de La Dracénie

    Draguignan, 83007, France

  • Unité Douleur et Soins Palliatifs, CH La Rochelle-Réaunis

    La Rochelle, 17019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.